Skip to main content
. 2020 Sep 19;259(2):413–424. doi: 10.1007/s00417-020-04930-2

Fig. 2.

Fig. 2

Viability of RPE cells after treatment with TLR agonists Pam (a), Poly I:C (b), or LPS (c) for 24 h. None of the applied agonists altered the viability of RPE cells (n = 3). Significance evaluated with the Kruskal–Wallis test